These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 3148511)

  • 1. Chromosome abnormalities in PHA-stimulated and non stimulated bone marrow cultures from patients with non Hodgkin lymphoma.
    Palka G; Fioritoni G; Lombardo M; Donti E; Calabrese G; Stuppia L; Di Marco G; Guanciali Franchi P; Parruti G; Geraci L
    Haematologica; 1988; 73(6):489-94. PubMed ID: 3148511
    [No Abstract]   [Full Text] [Related]  

  • 2. PHA/IL2: an efficient mitogen cocktail for cytogenetic studies of non-Hodgkin lymphoma and chronic lymphocytic leukemia.
    Morgan R; Chen Z; Richkind K; Roherty S; Velasco J; Sandberg AA
    Cancer Genet Cytogenet; 1999 Mar; 109(2):134-7. PubMed ID: 10087947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cytogenetic study on tumor cells in bone marrow in a case of lymphosarcoma].
    Zhang WD
    Zhonghua Yi Xue Za Zhi; 1983 Dec; 63(12):754-6. PubMed ID: 6426749
    [No Abstract]   [Full Text] [Related]  

  • 4. Investigation of bone marrow involvement in malignant lymphoma using fluorescence in situ hybridization: possible utility in the detection of micrometastasis.
    Huh HJ; Min HC; Cho HI; Chae SL; Lee DS
    Cancer Genet Cytogenet; 2008 Oct; 186(1):1-5. PubMed ID: 18786435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chromosome abnormalities in malignant lymphoma in patients from Saitama.
    Maseki N; Kaneko Y; Sakurai M; Kurihara M; Sampi K; Shimamura K; Takayama S
    Cancer Res; 1987 Dec; 47(24 Pt 1):6767-75. PubMed ID: 3315191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chromosome studies in human hematologic diseases: non-Hodgkin's lymphomas.
    Slavutsky I; Labal de Vinuesa M; Estévez ME; Sen L; Dupont J; Larripa I
    Haematologica; 1987; 72(1):29-37. PubMed ID: 3108092
    [No Abstract]   [Full Text] [Related]  

  • 7. [Analysis of the non-Hodgkin lymphoma's clinic and blood marrow cytogenetics].
    Zhou M; Cen L; Xue YQ
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Oct; 23(5):568-70. PubMed ID: 17029212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytogenetic evaluation of bone marrow involvement in non-Hodgkin's lymphomas. A survey of 94 cases.
    Barbieri D; Michaux JL; Bosly A; van Hove W; Noens L; Drochmans A; Louwagie A; Tricot G; Boogaerts M; Vermaelen K
    Haematologica; 1984; 69(3):285-96. PubMed ID: 6432640
    [No Abstract]   [Full Text] [Related]  

  • 9. [Chromosome studies in malignant diseases of the lymphoplasmoreticular system with special reference to paraproteinemias].
    Siebner H
    Arztl Forsch; 1967 Oct; 21(10):359-81. PubMed ID: 4969911
    [No Abstract]   [Full Text] [Related]  

  • 10. A survey of chromosome findings in 47 cases of bovine lymphosarcoma (leukemia).
    Hare WC; Yang TJ; McFeely RA
    J Natl Cancer Inst; 1967 Mar; 38(3):383-92. PubMed ID: 6071481
    [No Abstract]   [Full Text] [Related]  

  • 11. Cytogenetic study of bone marrow and blood cells in patients with non-Hodgkin lymphoma before and after antitumor therapy.
    Ankina MA; Zavitaeva TA; Panferova TA; Shakhtarina SV; Pavlov VV
    Bull Exp Biol Med; 2007 Feb; 143(2):236-9. PubMed ID: 17970210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pharmacological correction of the cytogenetic effect of cyclophosphane].
    Voronova OL; Pashinskiĭ VG
    Vopr Onkol; 1991; 37(2):233-5. PubMed ID: 2014709
    [No Abstract]   [Full Text] [Related]  

  • 13. [The karyotype in paraproteinemias].
    Riva G; Spengler GA; Siebner H
    Minerva Med; 1971 May; 62(41):2081-4. PubMed ID: 4996374
    [No Abstract]   [Full Text] [Related]  

  • 14. Karyotype abnormalities in non-Hodgkin lymphomas.
    Gaunt KL; Callaghan J; Roberts DF
    Ann Genet; 1986; 29(2):82-7. PubMed ID: 3490211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparative evaluation of the cytogenetic effect of cyclophosphamide on lymphosarcoma cells and the bone marrow of intact and irradiated rats].
    Iakovleva TK
    Vopr Onkol; 1986; 32(7):67-71. PubMed ID: 3755558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonrandom chromosomal aberrations are associated with sites of tissue involvement in non-Hodgkin's lymphoma.
    Offit K; Richardson ME; Ceng QQ; Hampton A; Koduru PR; Jhanwar SC; Filippa DA; Lieberman PH; Clarkson B; Chaganti RS
    Cancer Genet Cytogenet; 1989 Jan; 37(1):85-93. PubMed ID: 2917335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early leukemic recurrence of non-Hodgkin lymphoma after high-dose anti-neoplastic therapy with autologous marrow rescue.
    Vaughan WP; Weisenburger DD; Sanger W; Gale RP; Armitage JO
    Bone Marrow Transplant; 1987 Apr; 1(4):373-8. PubMed ID: 3332145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Occult lymphoma cells prevalent in autologous marrow from non-Hodgkin's diffuse lymphoma.
    Yokoyama J; Fujimiya Y; Yamaguchi T; Shiga K; Saijo Y; Groveman DS; McBain JA; Suzuki Y; Ebina T
    Am J Hematol; 2003 May; 73(1):1-11. PubMed ID: 12701113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The role of stromal cell derived factor-1/CXCR4 biological axis in tumor metastasis of non-Hodgkin lymphoma].
    Zhang C; Cui GH; Liu F; Wu QL; Chen Y
    Zhonghua Yi Xue Za Zhi; 2007 Mar; 87(10):695-7. PubMed ID: 17553309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Bone marrow chromosomes in 172 patients with chronic myeloid leukemia].
    Michalová K; Musilová J; Jarosová M; Indrák K; Koudelová Z
    Vnitr Lek; 1988 Jul; 34(7):694-700. PubMed ID: 3176359
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.